AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 1-25/56
INFLUENCE OF AMIFOSTINE ON THE PHARMACOKINETICS OF CISPLATIN IN CANCER-PATIENTS
Authors: KORST AEC VANDERSTERRE MLT GALL HE FICHTINGERSCHEPMAN AMJ VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., INFLUENCE OF AMIFOSTINE ON THE PHARMACOKINETICS OF CISPLATIN IN CANCER-PATIENTS, Clinical cancer research, 4(2), 1998, pp. 331-336
INFLUENCE OF AMIFOSTINE ON THE PHARMACOKINETICS OF CISPLATIN IN CANCER-PATIENTS
Authors: KORST AEC VANDERSTERRE MLT GALL HE FICHTINGERSCHEPMAN AMJ VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., INFLUENCE OF AMIFOSTINE ON THE PHARMACOKINETICS OF CISPLATIN IN CANCER-PATIENTS, Clinical cancer research, 4(2), 1998, pp. 331-336
PHARMACOKINETICS OF CISPLATIN WITH AND WITHOUT AMIFOSTINE IN TUMOR-BEARING NUDE-MICE
Authors: KORST AEC BOVEN E VANDERSTERRE MLT FICHTINGERSCHEPMAN AMJ VANDERVIJGH WJF
Citation: Aec. Korst et al., PHARMACOKINETICS OF CISPLATIN WITH AND WITHOUT AMIFOSTINE IN TUMOR-BEARING NUDE-MICE, European journal of cancer, 34(3), 1998, pp. 412-416
MECHANISM(S) OF THE SCHEDULE-DEPENDENT INTERACTION BETWEEN GEMCITABINE (DFDC) AND CISPLATIN (CDDP) IN THE MURINE NONSMALL CELL LUNG (NSCL) TUMOR LEWIS LUNG
Authors: VANMOORSEL CJA VOORN DA VEERMAN G COMIJN EM SMID K VANDERVIJGH WJF POSTMUS PE VERMORKEN JB PINEDO HM PETERS GJ
Citation: Cja. Vanmoorsel et al., MECHANISM(S) OF THE SCHEDULE-DEPENDENT INTERACTION BETWEEN GEMCITABINE (DFDC) AND CISPLATIN (CDDP) IN THE MURINE NONSMALL CELL LUNG (NSCL) TUMOR LEWIS LUNG, Annals of oncology, 9, 1998, pp. 187-187
DETERMINANTS OF CPT-11 AND SN-38 ACTIVITIES IN HUMAN LUNG-CANCER CELLS
Authors: VANARKOTTE J KEDDE MA VANDERVIJGH WJF DINGEMANS AMC JANSEN WJM PINEDO HM BOVEN E GIACCONE G
Citation: J. Vanarkotte et al., DETERMINANTS OF CPT-11 AND SN-38 ACTIVITIES IN HUMAN LUNG-CANCER CELLS, British Journal of Cancer, 77(12), 1998, pp. 2171-2176
INFLUENCE OF IRON CHELATION ON THE ANTIOXIDANT ACTIVITY OF FLAVONOIDS
Authors: VANACKER SABE VANBALEN GP VANDENBERG DJ BAST A VANDERVIJGH WJF
Citation: Sabe. Vanacker et al., INFLUENCE OF IRON CHELATION ON THE ANTIOXIDANT ACTIVITY OF FLAVONOIDS, Biochemical pharmacology, 56(8), 1998, pp. 935-943
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY USING ELECTROCHEMICAL DETECTION FOR THE COMBINED MEASUREMENT OF AMIFOSTINE, WR-1065 AND THE DISULFIDES IN PLASMA
Authors: KORST AEC VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY USING ELECTROCHEMICAL DETECTION FOR THE COMBINED MEASUREMENT OF AMIFOSTINE, WR-1065 AND THE DISULFIDES IN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 693(1), 1997, pp. 167-174
PHARMACOKINETICS OF CARBOPLATIN WITH AND WITHOUT AMIFOSTINE IN PATIENTS WITH SOLID TUMORS
Authors: KORST AEC VANDERSTERRE MLT EELTINK CM FICHTINGERSCHEPMAN AMJ VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., PHARMACOKINETICS OF CARBOPLATIN WITH AND WITHOUT AMIFOSTINE IN PATIENTS WITH SOLID TUMORS, Clinical cancer research, 3(5), 1997, pp. 697-703
A DOSE-FINDING AND PHARMACOKINETIC STUDY OF REVERSAL OF MULTIDRUG-RESISTANCE WITH SDZ PSC-833 IN COMBINATION WITH DOXORUBICIN IN PATIENTS WITH SOLID TUMORS
Authors: GIACCONE G LINN SC WELINK J CATIMEL G STIELTJES H VANDERVIJGH WJF EELTINK C VERMORKEN JB PINEDO HM
Citation: G. Giaccone et al., A DOSE-FINDING AND PHARMACOKINETIC STUDY OF REVERSAL OF MULTIDRUG-RESISTANCE WITH SDZ PSC-833 IN COMBINATION WITH DOXORUBICIN IN PATIENTS WITH SOLID TUMORS, Clinical cancer research, 3(11), 1997, pp. 2005-2015
MONOHYDROXYETHYLRUTOSIDE, A DOSE-DEPENDENT CARDIOPROTECTIVE AGENT, DOES NOT AFFECT THE ANTITUMOR-ACTIVITY OF DOXORUBICIN
Authors: VANACKER SABE BOVEN E KUIPER K VANDENBERG DJ GRIMBERGEN JA KRAMER K BAST A VANDERVIJGH WJF
Citation: Sabe. Vanacker et al., MONOHYDROXYETHYLRUTOSIDE, A DOSE-DEPENDENT CARDIOPROTECTIVE AGENT, DOES NOT AFFECT THE ANTITUMOR-ACTIVITY OF DOXORUBICIN, Clinical cancer research, 3(10), 1997, pp. 1747-1754
PHARMACOKINETICS OF AMIFOSTINE AND ITS METABOLITES IN PATIENTS
Authors: KORST AEC EELTINK CM VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., PHARMACOKINETICS OF AMIFOSTINE AND ITS METABOLITES IN PATIENTS, European journal of cancer, 33(9), 1997, pp. 1425-1429
MULTIPLE CYCLES OF HIGH-DOSE DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HONKOOP AH VANDERWALL E FELLER N SCHUURHUIS GJ VANDERVIJGH WJF BOVEN E VANGROENINGEN CJ GIACCONE G HOEKMAN K VERMORKEN JB WAGSTAFF J PINEDO HM
Citation: Ah. Honkoop et al., MULTIPLE CYCLES OF HIGH-DOSE DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 8(10), 1997, pp. 957-962
17-BETA-ESTRADIOL HAS NO SHORT-TERM EFFECT ON THE ABSORPTION IN POSTMENOPAUSAL WOMEN
Authors: TENBOLSCHER M DEVALKDEROO GW BARTO R TINHOLT JT VANDERVIJGH WJF NETELENBOS JC
Citation: M. Tenbolscher et al., 17-BETA-ESTRADIOL HAS NO SHORT-TERM EFFECT ON THE ABSORPTION IN POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 508-508
PHARMACOKINETICS OF PACLITAXEL AND CARBOPLAT DOSE-ESCALATING AND DOSE-SEQUENCING STUDY IN WITH NON-SMALL-CELL LONG CANCER
Authors: HUIZING MT GIACCONE G VANWARMERDAM LJC ROSING H BAKKER PJM VERMORKEN JB POSTMUS PE VANZANDWIJK N KOOLEN MGJ HUININK WWTB VANDERVIJGH WJF BIERHORST FJ LAI A DALESIO O PINEDO HM VEENHOF CHN BEIJNEN JH
Citation: Mt. Huizing et al., PHARMACOKINETICS OF PACLITAXEL AND CARBOPLAT DOSE-ESCALATING AND DOSE-SEQUENCING STUDY IN WITH NON-SMALL-CELL LONG CANCER, Journal of clinical oncology, 15(1), 1997, pp. 317-329
PRECLINICAL SCREENING OF THE APPLICABILITY OF STRONTIUM AS A MARKER FOR INTESTINAL CALCIUM-ABSORPTION
Authors: SIPS AJAM BARTO R NETELENBOS JC VANDERVIJGH WJF
Citation: Ajam. Sips et al., PRECLINICAL SCREENING OF THE APPLICABILITY OF STRONTIUM AS A MARKER FOR INTESTINAL CALCIUM-ABSORPTION, American journal of physiology: endocrinology and metabolism, 35(3), 1997, pp. 422-428
IMPROVED P-32 POSTLABELING ASSAY FOR THE QUANTIFICATION OF THE MAJOR PLATINUM-DNA ADDUCTS
Authors: WELTERS MJP MALIEPAARD M JACOBSBERGMANS AJ BAAN RA SCHELLENS JHM MA JG VANDERVIJGH WJF BRAAKHUIS BJM FICHTINGERSCHEPMAN AMJ
Citation: Mjp. Welters et al., IMPROVED P-32 POSTLABELING ASSAY FOR THE QUANTIFICATION OF THE MAJOR PLATINUM-DNA ADDUCTS, Carcinogenesis, 18(9), 1997, pp. 1767-1774
CLINICAL-PHARMACOLOGY OF CARBOPLATIN ADMINISTERED IN COMBINATION WITHPACLITAXEL
Authors: VANWARMERDAM LJC HUIZING MT GIACCONE G POSTMUS PE HUININK WWT VANZANDWIJK N KOOLEN MGJ HELMERHORST TJM VANDERVIJGH WJF VEENHOF CHN BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., CLINICAL-PHARMACOLOGY OF CARBOPLATIN ADMINISTERED IN COMBINATION WITHPACLITAXEL, Seminars in oncology, 24(1), 1997, pp. 97-104
RELATIONSHIP BETWEEN THE PARAMETERS CELLULAR-DIFFERENTIATION, DOUBLING TIME AND PLATINUM ACCUMULATION AND CISPLATIN SENSITIVITY IN A PANEL OF HEAD AND NECK-CANCER CELL-LINES
Authors: WELTERS MJP FICHTINGERSCHEPMAN AMJ BAAN RA HERMSEN MAJA VANDERVIJGH WJF CLOOS J BRAAKHUIS BJM
Citation: Mjp. Welters et al., RELATIONSHIP BETWEEN THE PARAMETERS CELLULAR-DIFFERENTIATION, DOUBLING TIME AND PLATINUM ACCUMULATION AND CISPLATIN SENSITIVITY IN A PANEL OF HEAD AND NECK-CANCER CELL-LINES, International journal of cancer, 71(3), 1997, pp. 410-415
INFLUENCE OF SINGLE AND MULTIPLE DOSES OF AMIFOSTINE ON THE EFFICACY AND THE PHARMACOKINETICS OF CARBOPLATIN IN MICE
Authors: KORST AEC BOVEN E VANDERSTERRE MLT FICHTINGERSCHEPMAN AMJ VANDERVIJGH WJF
Citation: Aec. Korst et al., INFLUENCE OF SINGLE AND MULTIPLE DOSES OF AMIFOSTINE ON THE EFFICACY AND THE PHARMACOKINETICS OF CARBOPLATIN IN MICE, British Journal of Cancer, 75(10), 1997, pp. 1439-1446
DETERMINATION OF THE 2 DIASTEREOISOMERS OF LOBAPLATIN (D-19466) IN PLASMA ULTRAFILTRATE OF CANCER-PATIENTS WITH A NORMAL OR AN IMPAIRED KIDNEY OR LIVER-FUNCTION BY HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Authors: WELINK J PECHSTEIN B VANDERVIJGH WJF
Citation: J. Welink et al., DETERMINATION OF THE 2 DIASTEREOISOMERS OF LOBAPLATIN (D-19466) IN PLASMA ULTRAFILTRATE OF CANCER-PATIENTS WITH A NORMAL OR AN IMPAIRED KIDNEY OR LIVER-FUNCTION BY HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical applications, 675(1), 1996, pp. 107-111
RELATIONSHIP BETWEEN THE TUMOR-TISSUE PHARMACOKINETICS AND THE ANTIPROLIFERATIVE EFFECTS OF ANTHRACYCLINES AND THEIR METABOLITES
Authors: BOVEN E DEJONG J KUIPER CM BAST A VANDERVIJGH WJF
Citation: E. Boven et al., RELATIONSHIP BETWEEN THE TUMOR-TISSUE PHARMACOKINETICS AND THE ANTIPROLIFERATIVE EFFECTS OF ANTHRACYCLINES AND THEIR METABOLITES, European journal of cancer, 32A(8), 1996, pp. 1382-1387
AMIFOSTINE (ETHYOL(R)) - PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS IN-VIVO
Authors: VANDERVIJGH WJF KORST AEC
Citation: Wjf. Vandervijgh et Aec. Korst, AMIFOSTINE (ETHYOL(R)) - PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS IN-VIVO, European journal of cancer, 32A, 1996, pp. 26-30
A QUANTUM-CHEMICAL EXPLANATION OF THE ANTIOXIDANT ACTIVITY OF FLAVONOIDS
Authors: VANACKER SABE DEGROOT MJ VANDENBERG DJ TROMP MNJL DONNEOPDENKELDER G VANDERVIJGH WJF BAST A
Citation: Sabe. Vanacker et al., A QUANTUM-CHEMICAL EXPLANATION OF THE ANTIOXIDANT ACTIVITY OF FLAVONOIDS, Chemical research in toxicology, 9(8), 1996, pp. 1305-1312
STRUCTURAL ASPECTS OF ANTIOXIDANT ACTIVITY OF FLAVONOIDS
Authors: VANACKER SABE VANDENBERG DJ TROMP MNJL GRIFFIOEN DH VANBENNEKOM WP VANDERVIJGH WJF BAST A
Citation: Sabe. Vanacker et al., STRUCTURAL ASPECTS OF ANTIOXIDANT ACTIVITY OF FLAVONOIDS, Free radical biology & medicine, 20(3), 1996, pp. 331-342
PHARMACOKINETICS OF AMIFOSTINE AND ITS METABOLITES IN THE PLASMA AND ASCITES OF A CANCER-PATIENT
Authors: KORST AEC GALL HE VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., PHARMACOKINETICS OF AMIFOSTINE AND ITS METABOLITES IN THE PLASMA AND ASCITES OF A CANCER-PATIENT, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 162-166
Risultati: 1-25 | 26-50 | 51-56